DEVELOPMENT OF INHIBITORS OF RAD52 PROTEIN AGAINST BRCA-DEFICIENT BREAST CANCER

$595,440FY2020Defense Health AgencyDOD

Baruch S. Blumberg Institute, Doylestown PA

Investigators